1584-58-3

Basic information

• Product Name: 4-methyl-N-[3-(trifluoromethyl)phenyl]-
• Synonyms: 4-methyl-N-[3-(trifluoromethyl)phenyl]-;4-Toluenesulfonyl-(3-trifluoromethylanilide)
• CAS NO: 1584-58-3
• Molecular Formula: C₁₄H₁₂F₃NO₂S
• Molecular Weight: 315.3107896
• Mol File: 1584-58-3.mol
• Article Data: 18

Chemical Properties

• Melting Point: 94.5-96.5 °C
• Boiling Point: 388.9±52.0 °C(Predicted)
• Appearance: /
• Density: 1.380±0.06 g/cm3(Predicted)
• PKA: 7.70±0.10(Predicted)
• CAS DataBase Reference: 4-methyl-N-[3-(trifluoromethyl)phenyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: 4-methyl-N-[3-(trifluoromethyl)phenyl]-(1584-58-3)
• EPA Substance Registry System: 4-methyl-N-[3-(trifluoromethyl)phenyl]-(1584-58-3)

Safety Data

• Hazardous Substances Data: 1584-58-3(Hazardous Substances Data)

Upstream product

• 98-16-8 3-trifluoromethylaniline 
• 98-59-9 p-toluenesulfonyl chloride 
• 824-79-3 sodium 4-methylbenzenesulfinate 
• 98-46-4 3-trifluoromethylnitrobenzene 
• 70-55-3 toluene-4-sulfonamide 
• 98-15-7 3-chlorotrifluoromethylbenzene 
• 199188-30-2 3-(trifluoromethyl)phenyl trifluoromethanesulfonate 
• 401-78-5 3-bromo-1-trifluoromethylbenzene 
• 1423-26-3 (meta-(trifluoromethyl)phenyl)boronic acid 
• 401-81-0 m-trifluoromethylphenyl iodide 
• 1576-35-8 toluene-4-sulfonic acid hydrazide 
• 941-55-9 4-toluenesulfonyl azide 

Downstream Products

• 1253375-15-3 4-methyl-N-(3-(trifluoromethyl)phenyl)-N-vinylbenzenesulfonamide 
• 98-16-8 3-trifluoromethylaniline 
• 1416983-63-5 4-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]benzenesulfonamide 
• 1416983-65-7 4-methyl-N-[2-nitro-5-(trifluoromethyl)phenyl]benzenesulfonamide 

Relevant articles and documents

Synthesis and evaluation of 3-(4-(phenoxymethyl)phenyl)propanoic acid and N-phenylbenzenesulfonamide derivatives as FFA4 agonists

Free fatty acid receptor 4 (FFA4) has been recognized as an attractive target in metabolic diseases. To find potent and selective FFA4 agonist, 28 compounds of 3-(4-(phenoxymethyl)phenyl)propanoic acid and N-phenylbenzenesulfonamide derivatives were designed and synthesized, featuring O[sbnd]C and SO2-N linkage. For the O[sbnd]C linkage compounds, 1g showed the most potent FFA4 agonistic activity with a pEC50 of 5.81 ± 0.04 and exhibited at least 64-fold selectivity against FFA1. For SO2-N linkage agonists, 2m had a pEC50 of 5.66 ± 0.04 and displayed>46-fold selectivity against FFA1. Among these two series of compounds, 1g was the most potent agonist at FFA4 and the best selectivity against FFA1, demonstrated by docking simulation. Moreover, 1g showed receptor selectivity on other seven GPCRs. In anti-diabetic evaluation, 1g dose-dependently reduced blood glucose, which was better than a clinical phase III drug TAK875. This study provides guidance for FFA4 ligand design and drug optimization.

Fe-based metal-organic frameworks for the synthesis of N-arylsulfonamides via the reactions of sodium arylsulfinates or arylsulfonyl chlorides with nitroarenes in water

A newly developed chemoselective reaction of sodium arylsulfinates or arylsulfonyl chlorides with nitroarenes has been disclosed. The chemistry, in which non-toxic water and recyclable iron-based metal-organic frameworks are employed as the solvent and catalyst, respectively, provides an efficient approach for the generation of N-arylsulfonamides, which are widely present in biologically active compounds and drugs, rendering this methodology attractive to both synthetic and medicinal chemistry.

Palladium-catalyzed N-arylsulfonamide formation from arylsulfonyl hydrazides and nitroarenes

A palladium-catalyzed construction for N-arylsulfonamide from nitroarenes and arylsulfonyl hydrazides is developed. In this protocol, abundant and stable nitroarenes serve as the nitrogen sources by in situ reduction reaction of hydrogen released from arylsulfonyl hydrazides. No external oxidants or reductants are needed for this kind of transformation.